Cargando…

Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study

PURPOSE: Short telomeres and B vitamin deficiencies have been proposed as risk factors for age-related diseases and mortality that interact through oxidative stress and inflammation. However, available data to support this concept are insufficient. We aimed to investigate the predictive role of B vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pusceddu, Irene, Herrmann, Wolfgang, Kleber, Marcus E., Scharnagl, Hubert, Hoffmann, Michael M., Winklhofer-Roob, Brigitte M., März, Winfried, Herrmann, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230054/
https://www.ncbi.nlm.nih.gov/pubmed/31129702
http://dx.doi.org/10.1007/s00394-019-01993-8
_version_ 1783534871149281280
author Pusceddu, Irene
Herrmann, Wolfgang
Kleber, Marcus E.
Scharnagl, Hubert
Hoffmann, Michael M.
Winklhofer-Roob, Brigitte M.
März, Winfried
Herrmann, Markus
author_facet Pusceddu, Irene
Herrmann, Wolfgang
Kleber, Marcus E.
Scharnagl, Hubert
Hoffmann, Michael M.
Winklhofer-Roob, Brigitte M.
März, Winfried
Herrmann, Markus
author_sort Pusceddu, Irene
collection PubMed
description PURPOSE: Short telomeres and B vitamin deficiencies have been proposed as risk factors for age-related diseases and mortality that interact through oxidative stress and inflammation. However, available data to support this concept are insufficient. We aimed to investigate the predictive role of B vitamins and homocysteine (HCY) for mortality in cardiovascular patients. We explored potential relationships between HCY, B vitamins, relative telomere length (RTL), and indices of inflammation. METHODS: Vitamin B6, HCY, interleukin-6 (IL-6), high-sensitive-C-reactive protein (hs-CRP), and RTL were measured in participants of the Ludwigshafen Risk and Cardiovascular Health Study. Death events were recorded over a median follow-up of 9.9 years. RESULTS: All-cause mortality increased with higher concentrations of HCY and lower vitamin B6. Patients in the 4th quartile of HCY and vitamin B6 had hazard ratios (HR) for all-cause mortality of 2.77 (95% CI 2.28–3.37) and 0.41(95% CI 0.33–0.49), respectively, and for cardiovascular mortality of 2.78 (95% CI 2.29–3.39) and 0.40 (95% CI 0.33–0.49), respectively, compared to those in the 1st quartile. Multiple adjustments for confounders did not change these results. HCY and vitamin B6 correlated with age-corrected RTL (r = − 0.086, p < 0.001; r = 0.04, p = 0.031, respectively), IL-6 (r = 0.148, p < 0.001; r = − 0.249, p < 0.001, respectively), and hs-CRP (r = 0.101, p < 0.001; r = − 0.320, p < 0.001, respectively). Subjects with the longest telomeres had a significantly higher concentration of vitamin B6, but lower concentrations of HCY, IL-6, and hs-CRP. Multiple regression analyses identified HCY as an independent negative predictor of age-corrected RTL. CONCLUSIONS: In conclusion, hyperhomocysteinemia and vitamin B6 deficiency are risk factors for death from any cause. Hyperhomocysteinemia and vitamin B6 deficiency correlate with increased mortality. This correlation might, at least partially, be explained by accelerated telomere shortening induced by oxidative stress and systemic inflammation in these circumstances. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00394-019-01993-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7230054
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-72300542020-05-18 Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study Pusceddu, Irene Herrmann, Wolfgang Kleber, Marcus E. Scharnagl, Hubert Hoffmann, Michael M. Winklhofer-Roob, Brigitte M. März, Winfried Herrmann, Markus Eur J Nutr Original Contribution PURPOSE: Short telomeres and B vitamin deficiencies have been proposed as risk factors for age-related diseases and mortality that interact through oxidative stress and inflammation. However, available data to support this concept are insufficient. We aimed to investigate the predictive role of B vitamins and homocysteine (HCY) for mortality in cardiovascular patients. We explored potential relationships between HCY, B vitamins, relative telomere length (RTL), and indices of inflammation. METHODS: Vitamin B6, HCY, interleukin-6 (IL-6), high-sensitive-C-reactive protein (hs-CRP), and RTL were measured in participants of the Ludwigshafen Risk and Cardiovascular Health Study. Death events were recorded over a median follow-up of 9.9 years. RESULTS: All-cause mortality increased with higher concentrations of HCY and lower vitamin B6. Patients in the 4th quartile of HCY and vitamin B6 had hazard ratios (HR) for all-cause mortality of 2.77 (95% CI 2.28–3.37) and 0.41(95% CI 0.33–0.49), respectively, and for cardiovascular mortality of 2.78 (95% CI 2.29–3.39) and 0.40 (95% CI 0.33–0.49), respectively, compared to those in the 1st quartile. Multiple adjustments for confounders did not change these results. HCY and vitamin B6 correlated with age-corrected RTL (r = − 0.086, p < 0.001; r = 0.04, p = 0.031, respectively), IL-6 (r = 0.148, p < 0.001; r = − 0.249, p < 0.001, respectively), and hs-CRP (r = 0.101, p < 0.001; r = − 0.320, p < 0.001, respectively). Subjects with the longest telomeres had a significantly higher concentration of vitamin B6, but lower concentrations of HCY, IL-6, and hs-CRP. Multiple regression analyses identified HCY as an independent negative predictor of age-corrected RTL. CONCLUSIONS: In conclusion, hyperhomocysteinemia and vitamin B6 deficiency are risk factors for death from any cause. Hyperhomocysteinemia and vitamin B6 deficiency correlate with increased mortality. This correlation might, at least partially, be explained by accelerated telomere shortening induced by oxidative stress and systemic inflammation in these circumstances. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00394-019-01993-8) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2019-05-25 2020 /pmc/articles/PMC7230054/ /pubmed/31129702 http://dx.doi.org/10.1007/s00394-019-01993-8 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Contribution
Pusceddu, Irene
Herrmann, Wolfgang
Kleber, Marcus E.
Scharnagl, Hubert
Hoffmann, Michael M.
Winklhofer-Roob, Brigitte M.
März, Winfried
Herrmann, Markus
Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study
title Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study
title_full Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study
title_fullStr Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study
title_full_unstemmed Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study
title_short Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study
title_sort subclinical inflammation, telomere shortening, homocysteine, vitamin b6, and mortality: the ludwigshafen risk and cardiovascular health study
topic Original Contribution
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230054/
https://www.ncbi.nlm.nih.gov/pubmed/31129702
http://dx.doi.org/10.1007/s00394-019-01993-8
work_keys_str_mv AT puscedduirene subclinicalinflammationtelomereshorteninghomocysteinevitaminb6andmortalitytheludwigshafenriskandcardiovascularhealthstudy
AT herrmannwolfgang subclinicalinflammationtelomereshorteninghomocysteinevitaminb6andmortalitytheludwigshafenriskandcardiovascularhealthstudy
AT klebermarcuse subclinicalinflammationtelomereshorteninghomocysteinevitaminb6andmortalitytheludwigshafenriskandcardiovascularhealthstudy
AT scharnaglhubert subclinicalinflammationtelomereshorteninghomocysteinevitaminb6andmortalitytheludwigshafenriskandcardiovascularhealthstudy
AT hoffmannmichaelm subclinicalinflammationtelomereshorteninghomocysteinevitaminb6andmortalitytheludwigshafenriskandcardiovascularhealthstudy
AT winklhoferroobbrigittem subclinicalinflammationtelomereshorteninghomocysteinevitaminb6andmortalitytheludwigshafenriskandcardiovascularhealthstudy
AT marzwinfried subclinicalinflammationtelomereshorteninghomocysteinevitaminb6andmortalitytheludwigshafenriskandcardiovascularhealthstudy
AT herrmannmarkus subclinicalinflammationtelomereshorteninghomocysteinevitaminb6andmortalitytheludwigshafenriskandcardiovascularhealthstudy